Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis ; volume:13 ; number:1 ; day:16 ; month:11 ; year:2021 ; pages:57-73 ; date:1.2022
Diabetes therapy ; 13, Heft 1 (16.11.2021), 57-73, 1.2022
- Urheber
-
Gourdy, Pierre
Bonadonna, Riccardo C.
Freemantle, Nick
Mauricio, Didac
Müller-Wieland, Dirk
Bigot, Gregory
Mauquoi, Celine
Ciocca, Alice
Bonnemaire, Mireille
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-021-01179-8
- URN
-
urn:nbn:de:101:1-2022050219025417849432
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gourdy, Pierre
- Bonadonna, Riccardo C.
- Freemantle, Nick
- Mauricio, Didac
- Müller-Wieland, Dirk
- Bigot, Gregory
- Mauquoi, Celine
- Ciocca, Alice
- Bonnemaire, Mireille
- SpringerLink (Online service)
Ähnliche Objekte (12)
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis